Save the date for BONESUPPORT's capital markets day - Investor

BONESUPPORT HOLDING AB (publ), a leading company active in orthobiology for the treatment of skeletal injuries, will arrange a capital markets day (CMD) for investors, analysts and the media on Tuesday, November 28, 2023, starting at 13:30 CET.

The event will be held at Västra Trädgårdsgatan 19 in Stockholm and will be available afterwards on BONESUPPORT's website. The focus for the CMD is innovation and development within BONESUPPORT. CEO Emil Billbäck and other people from the management team as well as key opinion leaders (KOLs) in orthopedics will be present. More information will come later.

About BONESUPPORT™

BONESUPPORT (Nasdaq Stockholm: BONEX) develops and commercializes innovative injectable bio-ceramic bone graft substitutes that remodel to the patient’s own bone and have the capability of eluting drugs. BONESUPPORT’s bone graft substitutes are based on the patented technology platform CERAMENT. The company is conducting several clinical studies to further demonstrate the clinical and health economic benefits its products deliver. The company is based in Lund, Sweden, and the net sales amounted to SEK 329 million in 2022. Please visit www.bonesupport.com for more information.
BONESUPPORT and CERAMENT are registered trademarks of BONESUPPORT AB.